LOS ANGELES--(BUSINESS WIRE)--Advocates from AIDS Healthcare Foundation (AHF) stepped up efforts to ensure that Gilead Sciences, Inc. be held accountable for promoting off-label use of Truvada for use ...
The US Food and Drug Administration (FDA) will take an additional three months to review Gilead Science's pre-exposure prophylaxis (PrEP) drug Truvada (tenofovir/emtricitabine) to assess ...
Truvada is used to treat HIV infection in adults and children, and to prevent HIV in people at high risk through pre-exposure prophylaxis (PrEP). Common side effects include nausea, fatigue, diarrhea, ...
Friday, May 20, 2022 (San Diego, U.S.)—Research from the University of California released in Clinical Infectious Diseases demonstrates that ingestible sensor-enabled Truvada®, taken as pre-exposure ...
The “grade A” endorsement means that two additional drugs should be covered under the Affordable Care Act. By Apoorva Mandavilli Apoorva Mandavilli has reported on the H.I.V. epidemic for more than 20 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results